Table 2 Interventions and co-interventions of patients with early mobility levels 4–7, 1–3 and 0
|  | Early mobility 4–7 N = 85 | Early mobility 1–3 N = 356 | Early mobility 0 N = 1267 | p value mobility 4–7 versus 0 | p value mobility 1–3 versu 0 |
|---|---|---|---|---|---|
Number of patients receiving IPC at least for 1 day—no. (%) | 46 (54.1) | 190 (53.4) | 677 (53.4) | 0.90 | 0.98 |
Use of graduated compression stockings—no. (%) | 1 (1.2) | 3 (0.8) | 9 (0.7) | 0.48^ | 0.73^ |
Pharmacologic thromboprophylaxis | Â | Â | Â | Â | Â |
 Prophylactic UFH | 49 (57.6) | 176 (49.4) | 819 (64.6) | 0.19 | < 0.0001 |
 Prophylactic LMWH | 39 (45.9) | 205 (57.6) | 556 (43.9) | 0.72 | < 0.0001 |
Anti-platelet therapy—no. (%) |  |  |  |  |  |
 Aspirin | 20 (23.5) | 69 (19.4) | 397 (31.3) | 0.13 | < 0.0001 |
 Clopidogrel | 4 (4.7) | 27 (7.6) | 155 (12.2) | 0.04 | 0.01 |
New renal replacement therapy—no. (%) | 6 (7.1) | 24 (6.7) | 196 (15.5) | 0.04 | < 0.0001 |
Central venous catheters including dialysis catheters—no. (%) |  |  |  |  |  |
 Femoral | 8 (9.4) | 51 (14.3) | 283 (22.3) | 0.0050 | 0.0010 |
 Jugular or subclavian | 37 (43.5) | 111 (31.2) | 767 (60.5) | 0.0020 | < 0.0001 |
 Peripherally inserted central catheter | 11 (12.9) | 32 (9.0) | 144 (11.4) | 0.66 | 0.20 |
 None | 35 (41.2) | 196 (55.1) | 345 (27.2) | 0.0056 | < 0.0001 |